Raltitrexed arterial infusion chemotherapy analysis |
| |
Authors: | Jun Liang Yuanlong Chen Huijuan Pan Ying Qian Dan Xu Min Li |
| |
Institution: | Department of 0ncology, The People’s Hospital of Wuxi Huishan Region, Wuxi 214187, China |
| |
Abstract: | Objective The aim of this study was to analysis raltitrexed by the safety and efficacy of intra-arterial infusion chemotherapy. Methods Forty-seven cases in different parts of cancer patients, interventional methods, based on digital subtraction angiography (DSA) prompt, raltitrexed-based chemotherapy, the tumor nourish artery infusion chemotherapy. Patients with postoperative chemotherapy side effects and complications, and efficacy assessments. Results Forty-seven patients, 2 patients had II–III degree of bone marrow suppression, the rate was 4.26%, 34 cases of I to II degree gastrointestinal reactions, 1 case of grade III gastrointestinal reactions, the incidence of 2.13%, and 1 case mild diarrhea. I degrees or more chemotherapy-related adverse reactions did not occur in this group of patients. All patients received at least 2 times arterial infusion chemotherapy, complete remission (CR) 3 cases, partial remission (PR) 11 cases, stable disease (SD) 17 cases, disease progression (PD) 6 cases, total effective rate of treatment 87.23%. Conclusion Raltitrexed for intra-arterial chemotherapy is safe and effective. However, due to the small number of this group of patients, time is short, its safety, efficacy and long-term efficacy needs further observation and validation. |
| |
Keywords: | raltitrexed transcatheter arterial chemo-infusion security validity |
本文献已被 万方数据 SpringerLink 等数据库收录! |
|